MarketCap
Facebook
X
TelegramQuartalsbericht 2026-Q1
hinzugefügt 08.05.2026
Pacific Biosciences of California ROCE 2011-2026 | PACB
ROCE Jährlich Pacific Biosciences of California
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -10354.48 | -93.63 | -47.69 | -54.57 | -26.6 | -31.11 | -101.73 | -70.43 | -77.77 | -68.43 | -56.15 | -67.56 | -68.24 | -82.08 | -55.17 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -26.6 | -10354.48 | -750.38 |
ROCE Vierteljährlich Pacific Biosciences of California
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1001.95 | -662.88 | -590.85 | -530.44 | -62.37 | -73.17 | -70.43 | -47.92 | -35.38 | -47.29 | -46.46 | -45.61 | -32.43 | -41.29 | -43.93 | -45.98 | -35.42 | -42.63 | -40.78 | -35.98 | -23.97 | -56.59 | -100.58 | -137.96 | -183.09 | -177.31 | -147.74 | -122.41 | -88.54 | -85.53 | -88.95 | -98.21 | -104.28 | -101.54 | -96.26 | -89.28 | -84.15 | -64.48 | -41.16 | -35.26 | -39.62 | -70.74 | -89.6 | -107.46 | -114.39 | -106.4 | -119.91 | -115.5 | -112.09 | -107.34 | -99.17 | -90.88 | -86.25 | -84.68 | -20.62 | -25.15 | - | - | - | -18.26 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -18.26 | -1001.95 | -120.5 |
ROCE anderer Aktien in der Diagnostik & Forschung
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
Fulgent Genetics
FLGT
|
-8.19 | $ 19.5 | 7.5 % | $ 600 M | USA |
 |
Celcuity
CELC
|
-171.24 | $ 92.47 | 3.96 % | $ 4.32 B | USA |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 5.76 | 11.41 % | $ 7.66 M | USA |
 |
Guardant Health
GH
|
440.3 | $ 133.06 | 4.75 % | $ 16.7 B | USA |
 |
Castle Biosciences
CSTL
|
-9.09 | $ 21.6 | 5.93 % | $ 626 M | USA |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
63.01 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 23.12 | 3.63 % | $ 1.23 B | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
ICON Public Limited Company
ICLR
|
4.82 | $ 152.8 | 6.18 % | $ 12 B |  Irlanda |
 |
Check-Cap Ltd.
CHEK
|
-69.04 | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 1.79 | 2.29 % | $ 7.92 M | USA |
 |
Illumina
ILMN
|
29.64 | $ 168.06 | -1.68 % | $ 26 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 102.82 | 2.56 % | $ 6.94 B | USA |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 185.79 | 3.29 % | $ 9.21 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 180.48 | 0.95 % | $ 24.3 B |  Schweiz |
 |
Medpace Holdings
MEDP
|
116.53 | $ 458.69 | 1.75 % | $ 13.2 B | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 11.31 | 11.54 % | $ 1.45 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
Natera
NTRA
|
-18.1 | $ 222.1 | 4.84 % | $ 30.4 B | USA |
 |
National Research Corporation
NRC
|
161.47 | $ 19.75 | 3.73 % | $ 442 M | USA |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 4.69 | 6.59 % | $ 434 M | USA |
 |
Personalis
PSNL
|
-33.71 | $ 12.1 | 12.24 % | $ 1.08 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
7.33 | $ 25.99 | 2.48 % | $ 24.6 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-111.94 | $ 7.01 | 4.32 % | $ 293 M | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
2.09 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.15 | 1.9 % | $ 4.94 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 260.97 | 0.79 % | $ 21.7 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-28.81 | $ 73.93 | 2.21 % | $ 4.42 B | USA |
 |
Thermo Fisher Scientific
TMO
|
14.5 | $ 482.03 | 1.7 % | $ 182 B | USA |
 |
Trinity Biotech plc
TRIB
|
-29.73 | $ 0.68 | -2.4 % | $ 244 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 9.12 | 3.52 % | $ 1.98 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 196.12 | 1.27 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | USA |
 |
Waters Corporation
WAT
|
7.05 | $ 376.47 | -0.87 % | $ 22.4 B | USA |